期刊文献+

妊娠合并甲型H_1N_1流感14例临床分析 被引量:1

Clinical Analysis of Pregnancy with Infection A H_1N_1 Influenza
下载PDF
导出
摘要 目的:探讨妊娠合并甲型H1N1流感的临床特点、治疗及其结局。方法:对2009年11月2日至2009年12月2日我院救治的14例妊娠期感染H1N1流感孕妇的临床情况进行总结性分析。结果:14例孕妇住院3~21天,平均8.6天。4例继续妊娠,7例手术结束妊娠,1例引产,2例自娩。13例新生儿存活,1例死亡,存活新生儿中5例早产,无新生儿H1N1感染病例,无孕妇死亡病例。结论:妊娠期感染H1N1流感孕妇更容易出现呼吸困难症状,病理妊娠及妊娠合并内科疾病者更易成为危重症病例。而早期应用奥司他韦能有效促进病情恢复,并未发现有母儿不良结局。 Objective:To explore the clinical characteristics, treatment and outcome of A H1N1 influenza infection in women with pregnancy. Methods:14 pregnancy women infected A H1N1 influenza in our hospital from November 2 to December 2 2009 were enrolled, and their clinical characteristics were analyzed. Re- sults:14 pregnant women stayed at hospital for 8.6 days in average (ranging from 3 to 21 days). For preg- nancy outcomes, 4 cases continued pregnancy, 7 cases were terminated by cesarean section, and onechose induced abortion, and two had vaginal delivery. For neonatal outcomes, 13 newborns survived (5 premature newborns), and one neonatal death. No newborn acquired A H1N1 infection, and no maternal death was observed. Conclusions:Pregnant women with H1 N1 influenza infection had dyspnea more fre- quently. Pathological pregnancy and pregnancy combined medical disease seemed to be more severe. The early use of oseltamivir may promote recovery effectively, and no adverse events were observed either in maternal side or newborn side.
作者 赵有红 左坤
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2012年第3期194-196,共3页 Journal of Practical Obstetrics and Gynecology
关键词 妊娠 甲型H1N1流感 奥司他韦 Pregnancy Influeza A virus H 1 N 1 Oseltamivir
  • 相关文献

参考文献7

  • 1World Health Organization. PandelIlie( H1 N1 )2009-update 78 [ EB/ OL]. 2009,12.
  • 2中华人民共和国卫生部.甲型HlNl流感诊疗方案(2009年).3版[EBOL].(2009-10-13)[2010-01-04].http://61.49.18.65/publicfiles/basiness/htmlfiles/mobyzs/s3586/200910/43111.htm.
  • 3中华人民共和国卫生部.甲型H1N1流感确诊病例出院标准(试行).中华临床感染病杂志,2009,2(3):136-136.
  • 4Jamieson DJ, Honein MA, Rasmussen SA, et al. H 1N1 2009 influ- enza virus infection during pregnancy in the USA[ J]. Lancet ,2009, 374(7) :451 -458.
  • 5Hayashi M, Yamane R, Tanaka M, et al. Pregnancy outcome after maternal exposure to oseltamivir phosphate during the first trimester: a case series survey [Japanese] [J]. Nihon Byoin Yakuzaishi Gak- kai Zasshi ,2009,45 (7) :547 - 550.
  • 6Freund B, Gravenstein S, Elliott, et al. Zanamivir: a review of clini- cal safety [ J ]. Drug Saf , 1999,21 (4) :267 - 281.
  • 7Worley KC, Roberts SW, Bawdon RE. The metabolim and transpla- cental transfer of oseltamivir in the exvivo human model [ J]. Infect Dis Obstet Gynecol, 2008, 28 (3) :327 - 331.

共引文献2

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部